Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT03933696

Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

Conditions: Mild Cognitive Impairment, Alzheimer Disease, Type2 Diabetes

Sex: All

Ages: 55 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 25

Sponsor: Icahn School of Medicine at Mount Sinai

Location: Rutgers University New Brunswick New Jersey

Summary

To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).

Eligibility Criteria

Inclusion Criteria: * Mild cognitive impairment * Mild Alzheimer's Disease * Sleep Disturbance * Live at home Exclusion Criteria: * Blindness * insulin-dependent diabetes patients * macular degeneration * severe sleep apnea

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03933696). StuddyBuddy aggregates publicly available trial information.